This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Aug;20(8):1007-1017.

doi: 10.1016/j.jtho.2025.04.008.

Lung Cancer in Jordan

Kamal Al-Rabi¹, Osama El Khatib², Raid Abdeljalil³, Yazan Talab⁴, Anoud Alnsour⁵, Jamal Khader⁵, Laith Al-Showbaki⁶, Abdalla Awidi⁷, Feras Al-Fararjeh⁶, Sameer Yaser¹, Taher Abu Hejleh², Husam Abu Jazar², Husam Haddad⁸, Naser Mahmoud², Anas Zayed², Abeer Yaseen², Tamer Al-Batsh², Omar Shamieh⁹, Akram Al Ibrahim¹⁰, Hikmat Abdel-Razeq¹, Nour Obeidat¹¹

Affiliations

Affiliations

¹ Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; School of Medicine, The University of Jordan. Amman, Jordan.
² Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
³ Department of Surgery, King Hussein Cancer Center, Amman, Jordan.
⁴ Department of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan.
⁵ Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
⁶ Division of Medical Oncology and Hematology, School of Medicine, The University of Jordan, Amman, Jordan.
⁷ Cell Therapy Center, University of Jordan, Amman, Jordan.
⁸ Pathology Department, King Hussein Cancer Center, Amman, Jordan.
⁹ Department of Palliative Care, King Hussein Cancer Center, Amman, Jordan.
¹⁰ Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
¹¹ Cancer Control Office, King Hussein Cancer Center, Amman, Jordan. Electronic address: Nobeidat@khcc.jo.

PMID: 40769630
DOI: 10.1016/j.jtho.2025.04.008

Editorial

Lung Cancer in Jordan

Kamal Al-Rabi et al. J Thorac Oncol. 2025 Aug.

. 2025 Aug;20(8):1007-1017.

doi: 10.1016/j.jtho.2025.04.008.

Authors

Kamal Al-Rabi¹, Osama El Khatib², Raid Abdeljalil³, Yazan Talab⁴, Anoud Alnsour⁵, Jamal Khader⁵, Laith Al-Showbaki⁶, Abdalla Awidi⁷, Feras Al-Fararjeh⁶, Sameer Yaser¹, Taher Abu Hejleh², Husam Abu Jazar², Husam Haddad⁸, Naser Mahmoud², Anas Zayed², Abeer Yaseen², Tamer Al-Batsh², Omar Shamieh⁹, Akram Al Ibrahim¹⁰, Hikmat Abdel-Razeq¹, Nour Obeidat¹¹

Affiliations

¹ Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; School of Medicine, The University of Jordan. Amman, Jordan.
² Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
³ Department of Surgery, King Hussein Cancer Center, Amman, Jordan.
⁴ Department of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan.
⁵ Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
⁶ Division of Medical Oncology and Hematology, School of Medicine, The University of Jordan, Amman, Jordan.
⁷ Cell Therapy Center, University of Jordan, Amman, Jordan.
⁸ Pathology Department, King Hussein Cancer Center, Amman, Jordan.
⁹ Department of Palliative Care, King Hussein Cancer Center, Amman, Jordan.
¹⁰ Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
¹¹ Cancer Control Office, King Hussein Cancer Center, Amman, Jordan. Electronic address: Nobeidat@khcc.jo.

PMID: 40769630
DOI: 10.1016/j.jtho.2025.04.008

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors declare no conflict of interest.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.